>

FRESENIUS MEDICAL (Italy) Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF0F00;color: white;font-size:4em;padding-top: 25px;;'>FR</div>
FME -- Italy Stock  

EUR 73.56  4.28  5.50%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding FRESENIUS MEDICAL CARE is 'Sell'. Macroaxis provides FRESENIUS MEDICAL buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding FME positions. The advice algorithm takes into account all of FRESENIUS MEDICAL CARE available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from FME buy-and-hold prospective. Please check FRESENIUS MEDICAL Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Equity
Refresh
Sell FRESENIUS MEDICALBuy FRESENIUS MEDICAL
Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon FRESENIUS MEDICAL CARE has a mean deviation of 0.8257, semi deviation of 0.8987, standard deviation of 1.37, variance of 1.88, downside variance of 2.71 and semi variance of 0.8076
Macroaxis provides unbiased buy, hold, or sell recommendation on FRESENIUS MEDICAL CARE that should be used to complement current analysts and expert consensus on FRESENIUS MEDICAL CARE. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure FRESENIUS MEDICAL is not overpriced, please confirm all FRESENIUS MEDICAL CARE fundamentals including its Current Valuation, Price to Sales, Net Income, as well as the relationship between Price to Earning and Gross Profit .

FRESENIUS MEDICAL Trading Alerts and Improvement Suggestions

FRESENIUS MEDICAL has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 13.71 B in total debt with debt to equity ratio (D/E) of 101.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. FRESENIUS MEDICAL CARE has Current Ratio of 0.96 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

FRESENIUS MEDICAL Returns Distribution Density

Mean Return0.13Value At Risk1.79
Potential Upside2.66Standard Deviation1.37
 Return Density 
    
  Distribution 

FRESENIUS MEDICAL Greeks

α
Alpha over DOW
=0.15
β
Beta against DOW=0.54
σ
Overall volatility
=1.67
Ir
Information ratio =0.0451

FRESENIUS MEDICAL Volatility Alert

FRESENIUS MEDICAL CARE has relatively low volatility with skewness of 0.42 and kurtosis of 3.05. However, we advise all investors to independently investigate FRESENIUS MEDICAL CARE to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare FRESENIUS MEDICAL to competition

FRESENIUS MEDICAL Fundamental Vs Peers

FundamentalsFRESENIUS MEDICALPeer Average
Return On Equity11.79 (0.31) 
Return On Asset4.66 (0.14) 
Profit Margin7.45 (1.27) 
Operating Margin12.73 (5.51) 
Current Valuation36.11 B16.62 B
Shares Outstanding300.44 M571.82 M
Price to Earning17.50 28.72 
Price to Book1.80 9.51 
Price to Sales1.29 11.42 
Revenue17.2 B9.43 B
Gross Profit5.15 B27.38 B
EBITDA3.02 B3.9 B
Net Income1.28 B570.98 M
Cash and Equivalents965.05 M2.7 B
Cash per Share3.21 5.01 
Total Debt13.71 B5.32 B
Debt to Equity101.20 48.70 
Current Ratio0.98 2.16 
Book Value Per Share40.87 1.93 K
Cash Flow from Operations2.49 B971.22 M
Earnings Per Share4.20 3.12 
Number of Employees120.73 K18.84 K
Beta1.12-0.15
Market Capitalization22.1 B19.03 B
Z Score0.68.72
Last Dividend Paid1.17